CANCER GENETICS, INC (51) | Uncategorized (14)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 30, 2022)
-
Description of Securities
(Filed With SEC on March 31, 2021)
-
Form of Wainwright Warrants dated February 16, 2021
(Filed With SEC on February 16, 2021)
-
Form of Engagement Agreement, dated September 18, 2020, as amended
(Filed With SEC on February 16, 2021)
-
Form of Placement Agent Warrants
(Filed With SEC on February 1, 2021)
-
At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020
(Filed With SEC on December 3, 2020)
-
Form of Underwriter Warrants of Cancer Genetics, Inc
(Filed With SEC on November 2, 2020)
-
Description of Securities
(Filed With SEC on May 29, 2020)
-
Standstill Agreement #2, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated May 3, 2019
(Filed With SEC on May 20, 2019)
-
Standstill Agreement, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated February 12, 2019
(Filed With SEC on April 16, 2019)
-
Offer Letter with Michael McCartney, dated May 14, 2018
(Filed With SEC on April 16, 2019)
-
Offer Letter with William Finger, dated December 14, 2018
(Filed With SEC on April 16, 2019)
-
Form of Placement Agent Warrants of Cancer Genetics, Inc
(Filed With SEC on January 29, 2019)
-
Form of Underwriter Warrants of Cancer Genetics, Inc
(Filed With SEC on January 10, 2019)